Myriad Genetics (NASDAQ: MYGN) surged 10.5% to $25.96. Myriad Genetics reported that CPT code pricing error should take a “week or two” to correct. Ladenburg Thalmann upgraded the stock from neutral to buy. Share volume was 260,000, compared to an all-day average of 1.8 million
